Trial

NCT05694169

A Study of Participants With Chronic Kidney Disease Previously Treated With REACT
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Prokidney
Collaborators
Condition
Diabetic Kidney Disease
Intervention
Renal Autologous Cell Therapy (REACT)
Why stopped
business decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-28